Is CHFHF or JNJ a better dividend investment in 2026?

CHFHF currently yields 17094.02% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: CHFHF offers higher current income.

What is the dividend yield difference between CHFHF and JNJ?

CHFHF has a forward dividend yield of 17094.02% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 17091.89 percentage points.

Home › Compare › CHFHF vs JNJ

CHFHF vs JNJ: Dividend Comparison 2026

CHFHF yields 17094.02% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHFHF wins by $448480.55M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CHFHF

● Live price

17094.02%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$448480.58M

Annual income

$35,081,332,972.06

Full CHFHF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — CHFHF vs JNJ

📍 CHFHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHFHF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHFHF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHFHF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHFHF

Annual income on $10K today (after 15% tax)

$1,452,991.45/yr

After 10yr DRIP, annual income (after tax)

$29,819,133,026.25/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, CHFHF beats the other by $29,819,129,040.26/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHFHF + JNJ for your $10,000?

CHFHF: 50%JNJ: 50%

100% JNJ50/50100% CHFHF

Portfolio after 10yr

$224240.31M

Annual income

$17,540,668,830.73/yr

Blended yield

7.82%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CHFHF

No analyst data

Altman Z

3.4

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHFHF buys

JNJ buys

No recent congressional trades found for CHFHF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHFHFJNJ

Forward yield	17094.02% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	28% ✓
Portfolio after 10y	$448480.58M ✓	$30.3K
Annual income after 10y	$35,081,332,972.06 ✓	$4,689.40
Total dividends collected	$375301.42M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CHFHF vs JNJ ($10,000, DRIP)

Year	CHFHF Portfolio	CHFHF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$865,401	$854,700.85	$10,592	$272.30	+$854.8K → CHFHF
2	$35,489,477	$34,563,497.67	$11,289	$357.73	+$35.48M → CHFHF
3	$700,321,674	$662,347,933.68	$12,123	$472.89	+$700.31M → CHFHF
4	$6,856,941,363	$6,107,597,172.29	$13,141	$629.86	+$6856.93M → CHFHF
5	$35,280,985,673	$27,944,058,414.43	$14,408	$846.81	+$35280.97M → CHFHF
6	$104,937,767,873	$67,187,113,203.41	$16,021	$1,151.60	+$104937.75M → CHFHF
7	$205,665,443,685	$93,382,032,060.80	$18,122	$1,588.22	+$205665.43M → CHFHF
8	$305,584,261,635	$85,522,236,892.13	$20,930	$2,228.20	+$305584.24M → CHFHF
9	$386,354,440,961	$59,379,281,010.83	$24,792	$3,191.91	+$386354.42M → CHFHF
10	$448,480,584,800	$35,081,332,972.06	$30,274	$4,689.40	+$448480.55M → CHFHF

CHFHF vs JNJ: Complete Analysis 2026

CHFHF — Stock

China Art Financial Holdings Limited, an investment holding company, operates as an art finance service provider in the People's Republic of China. The company operates through three segments: Art and Asset Pawn Business, Art and Asset Auction Business, and Art and Asset Sales Business. It provides pawn loan services secured by artworks and assets as collateral. The company's artwork collateral portfolio primarily includes zisha artworks, as well as paintings and calligraphies, and jewel artworks. It also offers online art auction services and agency services. The company was founded in 2004 and is headquartered in Yixing, the People's Republic of China. China Art Financial Holdings Limited is a subsidiary of Intelligenesis Investment Co., Ltd.

Full CHFHF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this CHFHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHFHF vs SCHD CHFHF vs JEPI CHFHF vs O CHFHF vs KO CHFHF vs MAIN CHFHF vs ABBV CHFHF vs MRK CHFHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.